Saroja Pharma Industries India Q2 Results
- BSE: -
- NSE: SAROJA
- ISIN: INE0PCL01011
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
33.00
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Tue 28 Apr, 2026 | 15:40:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹38.36 Cr.(104.87%)
- Operating Profit₹0.91 Cr.(-16.32%)
- Profit After Tax₹0.57 Cr.(69.89%)
- Operating Margin2.36%(NA%)
Note: Comparison is on YoY basis
Quarterly - Saroja Pharma Industries India Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 37.45 | - | N/A | 17.64 | 112.30% |
| Depreciation/ Amortization | 0.06 | - | N/A | 0.05 | 13.91% |
| Operating Income | 0.91 | - | N/A | 1.08 | -16.32% |
| Net Income | 0.57 | - | N/A | 0.34 | 69.89% |
| Other Operating Expenses Total | 0.59 | - | N/A | 0.58 | 2.85% |
| Net Income Before Taxes | 0.78 | - | N/A | 0.46 | 68.45% |
| Total Revenue | 38.36 | - | N/A | 18.72 | 104.87% |
| Selling/ General/ Admin Expenses Total | 0.62 | - | N/A | 0.59 | 5.37% |
| Diluted Normalized EPS | 1.42 | - | N/A | 0.83 | 71.08% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.